📰 Medication Errors News
Page 6 - Medication Errors News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medication Errors. Real-time updates on events, politics, business and more.
July 7, 2022
/PRNewswire/ -- The "APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)),...
July 7, 2022
/PRNewswire/ -- The "APAC Infusion Pumps Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Volumetric, Insulin, Syringe, Ambulatory)),...
June 30, 2022
30.06.2022 - Pfizer Inc. (NYSE: PFE) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for patients who are at high ...
June 23, 2022
/PRNewswire/ -- Brand Institute, the global leader in pharmaceutical and healthcare-related name development, recently celebrated the 15-year anniversary of...
June 7, 2022
Pfizer Inc. (NYSE: PFE) announced today that it will further strengthen its commitment to United States manufacturing with a $120 million investment at its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir [PF-07321332] tablets and ...
June 6, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
May 1, 2022
There have been several incidents of hospital staffers searching computerized medication cabinets with three or fewer letters and then administering or nearly administering the wrong drug. Hospitals are not required to report most drug mix-ups.
April 7, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...
April 7, 2022
- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented
March 22, 2022
22.03.2022 - Pfizer Inc. (NYSE: PFE) announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), to 95 low- and middle-income countries, ...